Literature DB >> 15370340

Black bile and psychomotor retardation: shades of melancholia in Dante's Inferno.

David A J Widmer1.   

Abstract

The history of melancholy depression is rich with images of movement retardation and mental dysfunction. The recent restoration of psychomotor symptoms to the diagnostic terminology of affective disorder is not novel to the students of medieval melancholia. The move back to the biology of this psychomotor dysfunction with the technical advances in brain imaging in recent years only echoes centuries-old writings on the centrality of movement changes in the depressive condition. The Inferno, the first cantica of Dante Alighieri's Commedia, has a wonderful abundance of allusions to the importance of psychomotor symptoms in describing the depressed individual. Slowed steps, garbled speech, frozen tears, these and many other images keep the physical manifestations of psychomotor suffering in the forefront of the reader's mind. Considering Medieval and Renaissance writings on melancholy suffering, it is fitting that Dante shows a bodily illness reflected in the hellish torments visited on the damned. From the souls of the sullen to those of the violent, the panorama of psychomotor symptoms plays a prominent role in the poem as well as in the medical and literary prose of succeeding centuries.

Entities:  

Mesh:

Year:  2004        PMID: 15370340     DOI: 10.1080/09647040490885529

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  2 in total

1.  Associations between observed in-home behaviors and self-reported low mood in community-dwelling older adults.

Authors:  Stephen M Thielke; Nora C Mattek; Tamara L Hayes; Hiroko H Dodge; Ana R Quiñones; Daniel Austin; Johanna Petersen; Jeffrey A Kaye
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

2.  Dante and asthenopia: a modern visual problem described during the Middle Ages.

Authors:  M A Riva; C Arpa; M Gioco
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.